| Serial Number | 97741761 |
| Word Mark | GLYCOVISION |
| Filing Date | Wednesday, January 4, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Sunday, July 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 5, 2023 |
| Goods and Services | Platform as a Service (PAAS) featuring computer software platforms for medical and scientific research, identifying biomarkers for diseases, drug discovery, glycoproteomic research and analysis and reporting, and medical and scientific laboratory services; scientific and medical research services; scientific research, namely, identifying biomarkers for specific diseases; scientific research analysis services for blood and other bodily fluids, specifically, blood, bodily fluid, and biological specimen analysis services; scientific, technological, and medical research and data analysis services in the nature of bioanalytical testing services and biomarker discovery services; scientific and medical research in the fields of oncology, mass spectrometry, cellular analysis, glycoproteomics, biomarker discovery, and drug discovery; scientific, technological, and data analysis services, namely, glycoproteomic research, analysis services in the nature of protein and cellular analyses, and a glycoproteomic solution featuring artificial intelligence; scientific and medical laboratory services; medical research services via collecting, analyzing, and reporting glycoproteomic data for blood, bodily fluids, and other biological specimens |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Venn Biosciences Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Venn Biosciences Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Saturday, January 7, 2023 | NEW APPLICATION ENTERED |
| Wednesday, September 27, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, January 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 12, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, September 19, 2023 | PRIORITY ACTION WRITTEN |
| Tuesday, September 19, 2023 | PRIORITY ACTION E-MAILED |
| Tuesday, September 19, 2023 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, September 27, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, October 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, July 21, 2024 | SOU EXTENSION 1 GRANTED |
| Sunday, July 21, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, December 5, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sunday, July 21, 2024 | SOU TEAS EXTENSION RECEIVED |